New Zealand markets closed

Zealand Pharma A/S (ZEAL.CO)

Copenhagen - Copenhagen Real-time price. Currency in DKK
Add to watchlist
942.00+3.50 (+0.37%)
As of 11:47AM CEST. Market open.
Currency in DKK

Valuation measures4

Market cap (intra-day) 66.30B
Enterprise value 64.69B
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)161.18
Price/book (mrq)23.36
Enterprise value/revenue 187.91
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.64
52-week change 3279.96%
S&P500 52-week change 325.87%
52-week high 3970.00
52-week low 3212.20
50-day moving average 3677.82
200-day moving average 3502.33

Share statistics

Avg vol (3-month) 3330.15k
Avg vol (10-day) 3607.15k
Shares outstanding 570.65M
Implied shares outstanding 671.44M
Float 853.7M
% held by insiders 10.14%
% held by institutions 148.55%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin -214.60%
Operating margin (ttm)-1,695.54%

Management effectiveness

Return on assets (ttm)-16.45%
Return on equity (ttm)-42.08%

Income statement

Revenue (ttm)344.25M
Revenue per share (ttm)5.82
Quarterly revenue growth (yoy)10.70%
Gross profit (ttm)N/A
EBITDA -657.04M
Net income avi to common (ttm)-738.75M
Diluted EPS (ttm)-12.39
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)3.23B
Total cash per share (mrq)51.92
Total debt (mrq)389.18M
Total debt/equity (mrq)13.71%
Current ratio (mrq)12.30
Book value per share (mrq)45.56

Cash flow statement

Operating cash flow (ttm)-452.67M
Levered free cash flow (ttm)-246.79M